Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in RXST — RxSight, Inc.

CIK 861177 NEW YORK, NY
Back to RXST Full portfolio

Position in RXST

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$310,938
-$86,443 QoQ
Shares Held
64,510
0.0% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 151 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXST Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,748,157,927 across 62 Medical Devices names. RXST ranks #39 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,835,753 $1,164,716,222
2 SYK
Stryker Corp
 2,689,376 $846,723,135
3 DXCM
Dexcom Inc
 11,261,876 $758,487,343
4 BSX
Boston Scientific Corp
 13,091,481 $558,744,402
5 EW
Edwards Lifesciences Corp
 5,488,643 $496,502,640
6 GEHC
GE HealthCare Technologies Inc.
 2,541,393 $162,674,562
7 ZBH
Zimmer Biomet Holdings, Inc.
 1,457,553 $125,480,733
8 BIO
Bio-Rad Laboratories, Inc.
 418,884 $122,988,525

All Filings in RXST

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $310,938 64,510
2026-03-31 $397,381 64,510
2025-12-31 $672,194 64,510
2025-09-30 $579,944 64,510
2025-06-30 $2,712,619 208,663
2025-03-31 $2,357,894 93,382
2024-12-31 $2,920,855 84,958
2024-09-30 $3,401,672 68,818
2024-06-30 $3,823,921 63,552
2024-03-31 $1,589,850 30,823
2023-12-31 $1,166,175 28,923
2023-09-30 $325,978 11,688